|
Dorzagliatin Clinical Trials
2 actively recruiting trials across 1 location
No change since May 2026
Pipeline
Phase 1: 1Phase 2: 1
Top Sponsors
- University of Pennsylvania1
- Chinese University of Hong Kong1
Indications
- Diabetes2
- Monogenic Diabetes1
- Pancreatic Insufficiency1
- Cystic Fibrosis-related Diabetes1
- Diabetes Mellitus1
Other1 trial
Philadelphia, Pennsylvania1 trial
Dorzagliatin in Pancreatic Insufficient Cystic Fibrosis
Hospital of University of Pennsylvania
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.